-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Atrial fibrillation (AF) is the main indication for oral anticoagulant (OAC) treatment, but it can cause spontaneous intracerebral hemorrhage (ICH)
.
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, this study aimed to assess the prevalence of AF in patients with ICH, time trends and early functional outcomes and death in patients
.
For the first time, patients with ICH were prospectively included in the population-based stroke registry in Dijon, France (2006-2017)
.
Researchers used ordinal and logistic regression to analyze the association between AF and early outcomes of ICH patients (ordinal modified Rankin scale score and death at discharge)
The prevalence of AF in diagnosing ICH patients and the use of OAC have increased over time .
The use of OAC before illness is associated with adverse outcomes after ICH.
Therefore, it is necessary to better identify the risk of ICH before starting or continuing OAC treatment in AF patients, and develop acute treatment and secondary prevention strategies for AF patients after ICH .
prevention
Original source:
Original source:Amélie Gabet.
et al.
Atrial Fibrillation in Spontaneous Intracerebral Hemorrhage, Dijon Stroke Registry (2006–2017) .